Fundación Para La Investigación Del Hospital Clínico De Valencia
Clinical trials sponsored by Fundación Para La Investigación Del Hospital Clínico De Valencia, explained in plain language.
-
Potassium binder may unlock lifesaving heart drugs for seniors
Disease control Recruiting nowThis study tests whether a drug called sodium zirconium cyclosilicate (SZC) can safely lower potassium levels in elderly patients with heart failure and chronic kidney disease. By controlling potassium, doctors hope to give these patients higher, more effective doses of heart-pro…
Phase: PHASE3 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated May 26, 2026 04:43 UTC
-
Pacemaker hope for stiff heart failure patients
Symptom relief Recruiting nowThis study is for people with heart failure with preserved ejection fraction (HFpEF), where the heart is stiff and doesn't fill properly. It tests whether a pacemaker can help the heart beat faster during exercise, improving exercise capacity and quality of life. 30 participants …
Phase: NA • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC
-
Iron infusion may boost Seniors' recovery after heart attack
Symptom relief Recruiting nowThis study tests whether giving intravenous iron to adults aged 65 and older with iron deficiency after a heart attack can improve their quality of life and reduce frailty. About 538 participants will be randomly assigned to receive either the iron infusion or standard care, and …
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC